Director
Merck
Philadelphia, PA, United States
Amanda Eiden PhD, MBA, MPH is a Director at Merck & Co., Inc and works in their Outcomes Research division. She conducts research studies to support vaccination access, uptake, and policies across all vaccines and age groups; topics include broad impacts of vaccination, valuation of vaccines, and vaccines confidence. At Merck she has also worked in Global Market Access on the pneumococcal program and Global Policy on the pipeline vaccines.
Prior to joining Merck, Amanda’s professional and academic experiences broadly spanned public health and research, with work designed to advance policies and best practices in the United States, Thailand, and Panama. Amanda holds a PhD from the University of Florida, an MPH from the University of South Florida, an MBA from Rutgers University, and a BS from the University of Wisconsin – Stevens Point, and she is Certified in Public Health through the National Board of Public Health Examiners.
Disclosure(s): Merck & Co., Inc.: Stocks/Bonds (Private Company)
Friday, October 18, 2024
12:30 PM – 12:35 PM US PT